Caspofungin for Candida endocarditis

Pediatr Infect Dis J. 2004 Apr;23(4):376. doi: 10.1097/00006454-200404000-00029.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Candida glabrata / drug effects
  • Candida glabrata / isolation & purification*
  • Candidiasis / diagnosis
  • Candidiasis / drug therapy*
  • Caspofungin
  • Dose-Response Relationship, Drug
  • Echinocandins
  • Endocarditis / diagnosis
  • Endocarditis / drug therapy*
  • Follow-Up Studies
  • Heart Septal Defects, Ventricular / diagnosis
  • Heart Septal Defects, Ventricular / surgery
  • Humans
  • Infant
  • Lipopeptides
  • Mycoses / diagnosis
  • Mycoses / drug therapy*
  • Peptides / administration & dosage*
  • Peptides, Cyclic*
  • Postoperative Complications / diagnosis
  • Postoperative Complications / drug therapy
  • Risk Assessment
  • Treatment Outcome

Substances

  • Echinocandins
  • Lipopeptides
  • Peptides
  • Peptides, Cyclic
  • Caspofungin